Phase 3 human clinical trial of Oxford vaccine begins in Pune

Phase 3 human clinical trial of Oxford vaccine begins in Pune

IndiaTimes

Published

The phase-III human clinical trial of the Covid-19 vaccine being developed by Oxford University, and manufactured by the Serum Institute of India (SII), began at the state-run Sassoon General Hospital here in Maharashtra on Monday, a senior official said.

Full Article